Kedi ve Köpeklerde Metisilin Dirençli Staphylococcus pseudintermedius (MRSP) Taşıyıcılığı

Dünya genelinde insan ve hayvanlarda stafilokokal infeksiyonlar giderek yaygınlaşmaktadır. Normal deri florasıüyelerinden olan stafilokoklar, fırsatçı patojen olarak çeşitli infeksiyonlara neden olabilmektedir. Fenotipik karakterdeStaphylococcus intermedius olarak tanımlanan izolatlar; S. intermedius grubunu (SIG) temsilen S. intermedius, S.pseudintermedius ve S. delphini dahil olmak üzere üç farklı türden oluşmaktadır. Staphylococcus pseudintermedius, nispetenyeni bir tür olup kedi ve köpeklerden sıklıkla izole edilebilmektedir. Yakın zamanda, metisilin dirençli S. pseudintermedius(MRSP) dünya çapında ortaya çıkmış ve yayılımının giderek artmakta olduğu bildirilmiştir. Günümüzün önemli halk sağlığısorunlarından olan çoklu antibiyotik dirençliliği, yeni kuşak antibiyotiklerin ve kombinasyonlarının kullanımını zorunlu halegetirmiştir. Antibiyotik dirençliliği kazanmış mikroorganizmalar, bugün nozokomiyal ve halk sağlığı ile ilişkili infeksiyonlaraneden olabilmektedir. Nitekim bu kapsamda, özellikle metisilin dirençli stafilokok suşları uzun süredir bu infeksiyonlarınortaya çıkışında önemli rol oynayarak, birçok hastanın ölümüne neden olabilmektedir. Veteriner hekimlikte sürekli artanantibiyotik kullanımı, antibiyotik dirençliliğinin yayılmasında önemli rol oynamaktadır. Son zamanlarda insan ve hayvanlardaMRSP taşıyıcılığı ile ilgili çalışmalar; MRSP izolasyonundaki artışı ve bu da özellikle pet hayvan sahiplerine bakterinintaşınmasındaki artışı göstermektedir. Uygulanan tedavilerdeki başarısızlık ise; metisilin direncini temsil eden sefoksitin veoksasilin antibiyotiklerine karşı direçlilik mekanizmasının artışını ifade etmektedir.

Transmission of Methicillin Resistant Staphylococcus pseudintermedius (MRSP) in Cats and Dogs

Staphylococcal infections are increasingly widespread worldwide in humans and animals. Staphylococci, which are members of normal skin flora, can cause various infections as opportunistic pathogens. The isolates identified as Staphylococcus intermedius in phenotypic character; S. intermedius group (SIG) is composed of three different species including S. intermedius, S. pseudintermedius and S. delphini. Staphylococcus pseudintermedius, a relatively new species, is frequently isolated from cats and dogs. Recently, methicillin-resistant S. pseudintermedius (MRSP) has emerged worldwide and has been reported increasingly. Multiple antibiotic resistance, one of the public health problems, has made necessary to use new generation antibiotics and combinations. Today, antibiotic resistance of microorganisms causes nosocomial and public health related infections. Methicillin resistant staphylococci strains have played an important role in the emergence of these infections for a long time and cause many patients to die. The increasing use of antibiotics in veterinary medicine plays an important role in the spread of antibiotic resistance. Recent studies about the carriage of MRSP in humans and animals showed that increase of MRSP isolation and related to high rate of bacterial transmission to pet owners. The failure in applied treatments indicates that increased of resistance mechanism against cefoxitin and oxacillin antibiotics which representing methicillin resistance.

PDF

___

1. Rubin JE., Chirino-Trejo M., 2011. Prevalence, sites of colonization and antimicrobial resistance among Staphylococcus pseudintermedius isolated from healthy dogs in Saskatoon. Canada J Vet Diagn Invest, 23, 351-354.
2. Fitzgerald RJ., 2009. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of methicillin resistance. Vet Dermatol, 20, 490-495.
3. Paul NC., Moodley A., Ghibaudo G., Guardabassi L., 2011. Carriage of methicillin-resistant Staphylococcus pseudintermedius in small animal veterinarians: Indirect evidence of zoonotic transmission. Zoonoses Public Hlth, 58, 533-539.
4. Hajek V., 1976. Staphylococcus intermedius, a new species isolated from animals. Int J Syst Bacteriol, 26, 401-408.
5. Devriese LA., Vancanneyt M., Baele M., Vaneechoutte M., De Graef E., Snauwaert C., Cleenwerck I., Dawyndt P., Swings J., Decostere A., Haesebrouck F., 2005. Staphylococcus pseudintermedius sp. nov., a coagulase positive species from animals. Int J Syst Evol Microbiol, 55, 1569-1573.
6. Varardo PE., Kilpper-Balz R., Biavaasco F., Satta G., Schleifer KH., 1988. Staphylococcus delphini sp. nov., a coagulase-positive species isolated from dolphins. Int J Syst Bacteriol, 38, 436-439.
7. Bannoehr J., Franco A., Lurescia M., Battisti A., Fitzgerald J., 2009. Molecular diagnostic identification of Staphylococcus pseudintermedius. J Clin Microbiol, 47, 469-471.
8. Sasaki T., Kikuchi K., Tanaka Y., Takahashi N., Kamata S., Hiramatsu K., 2007. Reclassification of phenotypically identified Staphylococcus intermedius strains. J ClinMicrobiol, 45, 2770- 2778.
9. van Duijkeren E., Catry B., Greko C., Moreno MA., Pomba MC., Pyorala S., Ruzauskas M., Sanders P., Threlfall EJ., Torren-Edo J., Törneke K., 2011. Review on methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother, 66, 2705-2714.
10. Sing A., Walker M., Roussea J., Weese JS., 2013. Characterization of the biofilm forming ability of Staphylococcus pseudintermedius from dogs. BMC Vet Res, 9, 93.
11. Allaker RP., Lloyd DH., Simpson AI., 1992. Occurrence of Staphylococcus intermedius on the hair and skin of normal dogs. Res Vet Sci, 52, 174- 176.
12. Griffeth GC., Morris DO., Abraham JL., Shofer FS., Rankin SC., 2008. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet Dermatol, 19, 142-149.
13. Fazakerley J., Nuttall T., Sales D., Schmidt V., Carter SD., Hart CA., McEwan NA., 2009. Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs. Vet Dermatol, 20, 179-184.
14. Kasai T., Saegusa S., Shirai M., Murakami M., Kato Y., 2016. New categories designated as healthcare-associated and communityassociated methicillin-resistant Staphylococcus pseudintermedius in Dogs. Microbiol Immunol, 60, 540-551.
15. Priyantha R., Gaunt MC., Rubin JE., 2016. Antimicrobial susceptibility of Staphylococcus pseudintermedius colonizing healthy dogs in Saskatoon, Canada. Can Vet J, 57, 65-69.
16. Abraham JL., Morris DO., Griffeth GC., Shofer FS., Rankin SC., 2007. Surveillance of healthy cats and cats with inflammatory skin disease for colonization of the skin by methicillin resistant coagulase-positive staphylococci and Staphylococcus schleiferi ssp. schleiferi. Vet Dermatol, 18, 252-259.
17. Büttner JN., Schneider M., Csokai J., Müller E., Eule JC., 2018. Microbiota of the conjunctival sac of 120 healthy cats. Vet Ophthalmol, 00, 1-9.
18. Chrobak- Chimel D., Golke A., Dembele K., Cwiek K., Kizerwetter-Swida M., Rzewuska M., Binek M., 2018. Staphylococcus pseudintermedius, both commensal and pathogen. Med Weter, 74, 362- 370.
19. van Duijkeren E., Kamphuis M., van der Mije IC., Laarhoven LM., Wagenaar JA., Houwers DJ., 2011. Transmission of methicillin-resistant Staphylococcus pseudintermedius between infected dogs and cats and contact pets, humans and the environment in households and veterinary clinics. Vet Microbiol, 150, 338-343.
20. Wettsteın K., Descloux S., Rossano A., Perreten V., 2008. Emergence of methicillin-resistant Staphylococcus pseudintermedius in Switzerland: three cases of urinary tract infections in cats. Schweiz Arch Tierheilkd, 150, 339-343.
21. Bardiau M., Yamazaki K., Ote I., Misawa N., Mainil JG.,2013. Characterization of methicillin‐resistant Staphylococcus pseudintermedius isolated from dogs and cats. Microbiol Immunol, 57, 496-501.
22. Outerbridge CA., Affolter VK., Lyons LA., Crothers SL., Lam ATH., Bonenberger TE., Ihrke PJ., White SD., 2018. An unresponsive progressive pustular and crusting dermatitis with acantholysis in nine cats. Vet Dermatol, 19, -e33.
23. Bannoehr J., Guardabassi L., 2012. Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Vet Dermatol, 23, 253-266.
24. Paul NC., Damborg P., Guardabassı L., 2014. Damto-offspring transmission and persistence of Staphylococcus pseudintermedius clones within dog families. Vet Dermatol, 25,3-e2.
25. Sasaki T., Kikuchi K., Tanaka Y., Takahashi N., Kamata S., Hiramatsu K., 2007. Methicillinresistant Staphylococcus pseudintermedius in a veterinary teaching hospital. J Clin Microbiol, 45, 1118-1125.
26. McCarthy AJ., Harrison EM., Stanczak- Mrozek K., Leggett B., Waller A., Holmes MA., Lloyd DH., Lindsay JA., Loeffler A., 2015. Genomic insights into the rapid emergence and evolution of MDR in Staphylococcus pseudintermedius. J Antimicrob Chemother, 4, 997-1007.
27. Weese JS., van Duijkeren E., 2010. Methicillin resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol, 140, 418-429.
28. Van Hoovels L., Vankeerberghen A., Boel A., Van Vaerenbergh K., De Beenhouwer H., 2006. First case of Staphylococcus pseudintermedius infection in a human. J Clin Microbiol, 44, 4609- 4612.
29. Guardabassi L., Loeber M., Jacobson A., 2004. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet Microbiol, 98, 23-27.
30. Lozano C., Rezusta A., Ferrer I., Perez-Laguna V., Zarazaga M., Ruiz-Ripa L., Revillo MJ., Torres C., 2017. Staphylococcus pseudintermedius human infection cases in Spain: dog-to-human transmission. Vector Borne Zoonotic Dis, 17, 268- 270.
31. Kmieciak W., Szewczyk EM., 2018. Are zoonotic Staphylococcus pseudintermedius strains a growing threat for humans? Folia Microbiol, 63, 743-747.
32. Beck KM.,Waisglass SE., Dick HLN., Weese JS., 2012. Prevalence of meticillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma. Vet Dermatol, 23, 369- 375.
33. Martino LD., Nocera FP., Mallardo K., Nizza S., Masturzo E., Fiorito F., Iovae G., Catalanotti P., 2016. An update on microbiological causes of canine otitis externa in Campania Region, Italy. Asian Pac J Trop Biomed, 6, 384-389.
34. Sherer CB., Botoni LS., Coura FM., Silva RO., Santos RD., Heinemann MB., Costa-Val AP., 2018. Frequency and antimicrobial susceptibility of Staphylococcus pseudintermedius in dogs with otitis externa. Cienc Rural, 48,1-7.
35. Rota A., Corro M., Drigo I., Bortolami A., Borjesson S., 2015. Isolation of coagulase-positive staphylococci from bitches’ colostrum and milk and genetic typing of methicillin-resistant Staphylococcus pseudintermedius strains. BMC Vet Res, 11,160.
36. Schwarz S., Kadlec K., Strommenger B., 2008. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius detected in the BfT-GermVet monitoring programme 2004-2006 in Germany. J Antimicrob Chemother, 61, 282- 285.
37. Perreten V., Kadlec K., Schwarz S., Andersson GU., Finn M., Greko C., Moodley A., Kania SA., Frank LA., Bemis DA., Franco A., Iurescia M., Battisti A., Duim B., Wagenaar JA., van Duijkeren E., Weese JS., Fitzgerald JR., Rossano A., Guardabassi L., 2010. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother, 65, 1145-1154.
38. Sareyyüpoğlu B., Müştak HK., Cantekin Z., Diker KS., 2014. Methicillin Resistance in Staphylococcus pseudintermedius isolated from Shelter Dogs in Turkey. Kafkas Univ Vet Fak Derg, 20, 435-438.
39. Slettemeas JS., Mikalsen J., Sunde M., 2010. Further diversity of the Staphylococcus intermedius group and heterogenicity in the MboI restriction site used for Staphylococcus pseudintermedius species identification. J Vet Diagn Invest, 22, 756-759.
40. Verstappen KM., Huijbregts L., Spaninks M., Wagenaar JA., Fluit AC., Duim B., 2017. Development of real-time PCR for detection of Staphylococcus pseudintermedius using a novel automated comparison of whole-genome sequences. Plos One, 12, e0183925.
41. Schissler JR., Hillier A., Daniels JB., Cole LK., Gebreyes WA., 2009. Evaluation of clinical laboratory standards institute interpretive criteria for methicillin-resistant Staphylococcus pseudintermedius isolated from dogs. J Vet Diagn Invest, 21,684-688.
42. Clinical and Laboratory Standards Institute (CLSI) 2017. Performance Standards for Antimicrobial Susceptibility Testing. M02-A12/M07-A10, CLSI Standards and Guidelines, Wayne, PA.
43. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, 2019.
44. Pottumarthy S., Schapiro JM., Prentice JL., Houze YB., Swanzy SR., Fang FC., Cookson BT., 2004. Clinical isolates of Staphylococcus intermedius masquerading as methicillin-resistant Staphylococcus aureus. J Clin Microbiol, 42, 5881- 5884.
45. Arnold AR., Burnham CA., Ford BA., Lawhon SD., McAllister SK.,Lonsway D.,Albrecht V., Jerris RC., Rasheed JK.,Limbago B., Burd EM.,Westblade LF., 2016. Evaluation of an immunochromatographic assay for rapid detection of penicillin-binding protein 2a in Human and Animal Staphylococcus intermedius Group, Staphylococcus lugdunensis, and Staphylococcus schleiferi Clinical Isolates. J Clin Microbiol, 54, 745-748.